Unique histopathological features of graft biopsies with liver function abnormalities in living donor liver transplant patients receiving basiliximab induction therapy

Kazushige Sato, Satoshi Sekiguchi, Naoki Kawagishi, Yorihiro Akamatsu, Kazuyuki Ishida, Daizo Fukushima, Shigeto Miyagi, Ikuo Takeda, Masaaki Yamaguchi, Shirou Oguma, Keisei Fujimori, Akira Sato, Susumu Satomi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Induction with basiliximab (BXM) has been confirmed as an effective treatment regimen for prophylaxis of acute cellular rejection (ACR). From 1991 to 2008, 116 living donor liver transplantations (LDLTs) were performed. Among these, 50 were included in this study. We compared calcineurin inhibitor plus steroid treatment without BXM (n=14, control group) and with BXM (n=36, BXM group). Although the rates of biopsied patients with abnormal serum biochemical tests (SBTs) were similar in the control (10/14, 71.4%) and BXM (21/36, 58.3%) groups, ACR was diagnosed in 9/10 (90.0%) patients in the control group compared with 4/21 (19.0%) patients in the BXM group. In accordance with the histopathological diagnosis, there was a significant difference in the ratios of peripheral CD4+CD25+ T cells at fivewk after LDLT between patients with and without ACR in the BXM group. Next, we divided the 32 patients without ACR in the BXM group into two groups: biopsied patients with abnormal SBTs and non-biopsied patients. The donor age of the biopsied patients was significantly higher than that of the non-biopsied patients. Induction with BXM reduced the incidence of ACR, and unique pathological phenomena responsible for graft dysfunction after LDLT with an increased incidence of abnormal SBTs were observed.

Original languageEnglish
Pages (from-to)61-68
Number of pages8
JournalClinical Transplantation
Volume25
Issue number1
DOIs
Publication statusPublished - 2011 Jan 1

Keywords

  • Abnormal serum biochemical tests
  • Acute cellular rejection
  • Anti-IL-2R
  • Basiliximab
  • Donor age
  • Living donor liver transplantation

ASJC Scopus subject areas

  • Transplantation

Fingerprint Dive into the research topics of 'Unique histopathological features of graft biopsies with liver function abnormalities in living donor liver transplant patients receiving basiliximab induction therapy'. Together they form a unique fingerprint.

  • Cite this

    Sato, K., Sekiguchi, S., Kawagishi, N., Akamatsu, Y., Ishida, K., Fukushima, D., Miyagi, S., Takeda, I., Yamaguchi, M., Oguma, S., Fujimori, K., Sato, A., & Satomi, S. (2011). Unique histopathological features of graft biopsies with liver function abnormalities in living donor liver transplant patients receiving basiliximab induction therapy. Clinical Transplantation, 25(1), 61-68. https://doi.org/10.1111/j.1399-0012.2010.01219.x